Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2794)	4/26/2010 12:29:10 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

Looking at Board pf Directors addictions, OREX also added last week Wendy Dixon, Ph.D. to its board of directors .<g> finance.yahoo.com Apparently she may think that Contrave's combination of ingredients, naltrexone & bupropion has potential in controling hunger and or glutony.<g> At any rate, OREX is holding on its recent near term UT, while facing the resistance at $6.75 <g> The ACTAY is $13.50 <g> Although OREX has a good amount oc cash left, it has been burning its cash at a good rate.<g> The insiders hold >40%. They have already submitted an NDA for Contrave and there were no major side effects reported in the PIII. But with the big risks on FDA's decisions, I will just keep my target at $10. <g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2794)	5/12/2010 3:14:58 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ARWR is trading at its intraday H. It is up 6.62% on moderate volume of > 160Ks still about 0.12% of its ADV. bigcharts.marketwatch.com ARWR is scheduled to report its 2ndQ results tomorrow after the market close. There will also have a CC and webcast.<g> ARWR was able to trim its loss on the 1stQ in spite of lower revenues. The EL for the Yr. is around $0.15 vs. the L os $0.43 in 2009 As mentioned, the ACTAY is $9 but that is only one "analyst" opinion. I will just keep my target at $3 for a possible 100% gain from present levels. <g> bigcharts.marketwatch.com Bernard